Addiction News and Research

RSS

New, unique method to measure shopping addiction

A group of researchers at the Faculty of Psychology at the University of Bergen (UiB) have developed a new and unique method to measure shopping addiction: The Bergen Shopping Addiction Scale.

30 Sep 2015

Integrating addiction treatment into primary care lowers substance dependence in patients with HIV

A program developed at Boston Medical Center, which integrates addiction treatment into primary care for patients with or at risk for HIV, has been shown to lower patients' substance dependence and encourage their engagement in treatment.

30 Sep 2015

FDA accepts Braeburn's resubmission of Probuphine NDA for review

Braeburn Pharmaceuticals, an Apple Tree Partners company, today announced that the U.S. Food and Drug Administration has accepted Braeburn's resubmission of the Probuphine New Drug Application (NDA) for review and set February 27, 2016 as the target date for Agency action.

28 Sep 2015

Two-drug combination relieves depression in older adults

More than half of older adults with clinical depression don't get better when treated with an antidepressant. But results from a multicenter clinical trial that included Washington University School of Medicine in St. Louis indicates that adding a second drug — an antipsychotic medication — to the treatment regimen helps many of those patients.

28 Sep 2015

UK Biobank genetic study shows link between lung disease and smoking behaviour

New research published in The Lancet Respiratory Medicine and presented at this year's European Respiratory Society meeting in Amsterdam presents the first analyses of genetic data from the UK Biobank that reveal new associations with lung disease and smoking behaviour.

28 Sep 2015

Cannabinoid receptors of the brain control aversive memories that are crucial for survival

Memory is not a simple box of souvenirs; it is also, and most importantly, a safety system for organisms. With the help of negative memories, known as "aversive" memories, we can avoid a threat that we have already confronted. Researchers from Inserm and University of Bordeaux have just discovered that the cannabinoid receptors of the brain control these memories that are crucial for survival.

26 Sep 2015

ABAM Foundation accredits nine additional fellowship programs to expand training in addiction medicine

The American Board of Addiction Medicine Foundation today announced the accreditation of nine additional fellowship programs to train addiction medicine physicians. With the addition of these programs, the total number of ABAM Foundation accredited training programs has reached 36.

26 Sep 2015

NIH-supported study explores effects of substance use on adolescent brain development

The National Institutes of Health today awarded 13 grants to research institutions around the country as part of a landmark study about the effects of adolescent substance use on the developing brain.

26 Sep 2015

New guideline on the use of prescription medications for treatment of opioid addiction

Medications play an important role in managing patients with opioid use disorders, but there are not enough physicians with the knowledge and ability to use these often-complex treatments.

25 Sep 2015

Medication used for diabetes could be a valuable tool for treating alcohol dependence

A new study on mice and rats at Sahlgrenska Academy shows that a medication used for diabetes and obesity also could be a valuable tool for the treatment of alcohol dependence.

25 Sep 2015

Brain & Behavior Research Foundation announces recipients of NARSAD Young Investigator Grants

The Brain & Behavior Research Foundation today announced the award of its NARSAD Young Investigator Grants valued at more than $13 million to 191 of the world's most promising young scientists.

24 Sep 2015

ER visits can reduce underage drinking and associated problems

The results of a five-year trial from faculty at the University of Michigan Injury Center found giving youth in the emergency department a short intervention during their visit decreased their alcohol consumption and problems related to drinking over the following year.

23 Sep 2015

People in addiction treatment programs more likely to use tobacco

People in addiction treatment programs around the world use tobacco at two to three times the rate of people who are not being treated for addiction, according to a review of research studies from 20 countries other than the United States.

23 Sep 2015

TSRI study reveals key morphine regulator that may help develop less-addictive pain medications

Once used in the 18th century as currency to reverse the trade imbalance between China and Britain, opiates that contain morphine have been misunderstood almost continually ever since.

23 Sep 2015

New research supports health strategies to reduce harmful alcohol use in low-income countries

A new study of alcohol use in countries of all income levels shows that current use increases the risk of alcohol-related cancers and injury, with no reduction in risk of mortality or cardiovascular disease overall.

18 Sep 2015

Bionomics’ BNC210 Phase 1 trial for anxiety and depression meets primary endpoint

Bionomics Limited, a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of diseases of the central nervous system (CNS) and cancer, today reported positive data from the completed Phase 1 multiple ascending dose, placebo controlled clinical trial of BNC210, an orally administered negative allosteric modulator of the alpha-7 nicotinic acetylcholine receptor (alpha-7 receptor) being developed for the treatment of anxiety and depression.

16 Sep 2015

Three studies point to mGluR2 as new molecular target for addiction treatment

The latest issue of Biological Psychiatry presents the results of three studies implicating metabotropic glutamate receptor 2 (mGluR2) as a new molecular target for the treatment of addiction.

15 Sep 2015

Researchers examine neuroanatomical signature of schizophrenia in different ethnic groups

While it is known that the incidence and outward symptoms of schizophrenia are strongly influenced by ethnic factors--for instance, patients from Asian ethnicities are more likely to experience visual hallucinations, whereas patients from western cultures and Caucasian ethnicities are more likely to suffer from auditory hallucinations--it was unclear if brain deficits would differ amongst suffers from various ethnic backgrounds.

14 Sep 2015

Qualitative RPCI study evaluates attitudes toward smoking cessation in Northern Appalachia

Significant differences in attitudes toward smoking cessation are reported between two generations of smokers in Northern Appalachia in new research from Roswell Park Cancer Institute.

14 Sep 2015

Two St. Louis institutions collaborate to create Center for Clinical Pharmacology

St. Louis College of Pharmacy and Washington University School of Medicine in St. Louis are joining forces to find better, safer and more effective ways to use prescription medications to improve health. Researchers from the two institutions are collaborating to create the Center for Clinical Pharmacology.

14 Sep 2015

Addiction News and Research

New, unique method to measure shopping addiction

Integrating addiction treatment into primary care lowers substance dependence in patients with HIV

FDA accepts Braeburn's resubmission of Probuphine NDA for review

Two-drug combination relieves depression in older adults

UK Biobank genetic study shows link between lung disease and smoking behaviour

Cannabinoid receptors of the brain control aversive memories that are crucial for survival

ABAM Foundation accredits nine additional fellowship programs to expand training in addiction medicine

NIH-supported study explores effects of substance use on adolescent brain development

New guideline on the use of prescription medications for treatment of opioid addiction

Medication used for diabetes could be a valuable tool for treating alcohol dependence

Brain & Behavior Research Foundation announces recipients of NARSAD Young Investigator Grants

ER visits can reduce underage drinking and associated problems

People in addiction treatment programs more likely to use tobacco

TSRI study reveals key morphine regulator that may help develop less-addictive pain medications

New research supports health strategies to reduce harmful alcohol use in low-income countries

Bionomics’ BNC210 Phase 1 trial for anxiety and depression meets primary endpoint

Three studies point to mGluR2 as new molecular target for addiction treatment

Researchers examine neuroanatomical signature of schizophrenia in different ethnic groups

Qualitative RPCI study evaluates attitudes toward smoking cessation in Northern Appalachia

Two St. Louis institutions collaborate to create Center for Clinical Pharmacology

Pioneering Live Cell Imaging - Yokogawa's Impact and Innovations

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Latest News